Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,879 | -74,771 | -228,302 | -153,730 | -69,639 |
| Depreciation Amortization | 1,309 | 863 | 6,677 | 5,372 | 3,840 |
| Accounts receivable | 39,714 | 39,824 | -39,235 | 737 | 349 |
| Accounts payable and accrued liabilities | -2,780 | -1,886 | -9,211 | -4,760 | -3,384 |
| Other Working Capital | 20,646 | 19,552 | -61,468 | -63,603 | -64,310 |
| Other Operating Activity | -4,235 | -22,011 | 61,109 | 2,434 | -15,349 |
| Operating Cash Flow | $-91,225 | $-38,429 | $-270,430 | $-213,550 | $-148,493 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 44,373 | -5,608 | 112,384 | 61,129 | 1,300 |
| PPE Investments | -898 | -399 | -4,193 | -4,156 | -4,024 |
| Other Investing Activity | 0 | 0 | 94,765 | 94,765 | 94,765 |
| Investing Cash Flow | $43,475 | $-6,007 | $202,956 | $151,738 | $92,041 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,605 | N/A | N/A |
| Debt Repayment | -524 | -312 | -518 | -396 | -190 |
| Common Stock Issued | 1,337 | 640 | 23,812 | 21,968 | 21,921 |
| Other Financing Activity | -107 | -93 | -815 | -778 | -723 |
| Financing Cash Flow | $706 | $235 | $53,084 | $20,794 | $21,008 |
| Beginning Cash Position | 93,088 | 93,088 | 107,478 | 107,478 | 107,478 |
| End Cash Position | 46,044 | 48,887 | 93,088 | 66,460 | 72,034 |
| Net Cash Flow | $-47,044 | $-44,201 | $-14,390 | $-41,018 | $-35,444 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,225 | -38,429 | -270,430 | -213,550 | -148,493 |
| Capital Expenditure | -898 | -399 | -4,193 | -4,156 | -4,024 |
| Free Cash Flow | -92,123 | -38,828 | -274,623 | -217,706 | -152,517 |